Making a difference
We’re not interested in innovation for innovation’s sake — we back technologies that promote the social good. Learn more about our companies’ impact here.
OESH, a small business funded by the National Science Foundation (NSF), is developing 3D printers to create shoes that are healthy by design.
To learn more visit: https://oeshshoes.com/.
‘Moxi’ the robot that supports nurses – Diligent Robotics
Diligent Robotics, a small business funded by the National Science Foundation (NSF), created “Moxi,” a robot that supports clinical staff teams in acute care hospitals by executing logistical tasks so staff can focus on direct human care.
To learn more visit: https://diligentrobots.com/.
Sustainable ink from algae
Living Ink Technologies, a small business funded by the National Science Foundation (NSF), is developing ink from algae cells. The Colorado-based biomaterials company is “changing the way pigments are made” to use algae as a colorant. Its sustainable algae products could replace ink made from petroleum-based ink.
To learn more visit: https://livingink.co/.
A cheaper, easier way to test for malaria
For many in sub-saharan Africa, finding out if a fever is due to Malaria often means trekking long miles to a clinic for a relatively pricey blood test, and anxious hours of waiting before the results come in. But the Urine Malaria Test kit developed by Fyodor Biotechnologies has begun to change all that.
To learn more visit: https://www.fyodorbio.com/.
Device to treat stress urinary incontinence in women
Elidah created a medical device to help women with stress urinary incontinence - the inability to control the urge to urinate - a condition which impacts about one in three women.
To learn more visit: https://www.elidah.com/.
Monitoring internal and external network performance - ThousandEyes
Mohit Lad, CEO & Co-Founder of ThousandEyes
“The grants we received from NSF were instrumental in bootstrapping ThousandEyes and allowing us to focus on building the first version of our product and acquiring customers. By the time we raised our series A from Sequoia capital, we had a handful of well-known brands as customers with annual bookings of more than $250k, i.e. real revenue. Thanks to NSF, we were on our way to commercializing our technology.” -Mohit Lad, CEO & Co-Founder of ThousandEyes, a network intelligence platform for businesses, was founded by Lad and Ricardo Oliviera in 2010. In 2018, they have 220 employees and have raised nearly $110 million.
ThousandEyes delivers Network Intelligence—performance visibility and actionable insights on digital experience for every user and application over any network. It arms network engineers, operations teams, support/service desk staff, developers, and even business users with an accurate, up-to-the-moment understanding of the link between application delivery and underlying network dependencies and behaviors– both inside and outside the organization.
Robots that create custom mosaics - Artaic
“Without NSF funding, my company wouldn’t have been able to get off the ground. Early on, when we were too young and too risky for venture funding, NSF filled the gap with an SBIR Phase I grant. Now, after our Phase II is completed, we are a viable growth stage company that employs over 30 people and serves clients globally. The best part— our product is having a positive impact on society, giving people access to an ancient art form that was previously too costly and complex to create and install.”
Founder and CEO of Artaic, a small business funded by NSF, that designs and fabricates custom mosaic tile installations using robots.
AI helps medical professionals interpret, perform ultrasounds
Bay Lab uses artificial intelligence to help medical professionals perform and interpret ultrasounds.
To learn more visit: https://baylabs.io/.
Online access to mental health therapy
TAO Connect provides online mental health therapy.
To learn more visit: http://taoconnect.org/.
New drug delivery technology for tumor treatment
Shasqi, a small business funded by the National Science Foundation, is developing a new way to deliver drugs to specific locations within the body to more effectively treat diseases such as cancer. The team, led by physician and chemist Dr. Jose M. Mejia Oneto, has created a targeting system that could enable effective therapy with lower doses of drugs and fewer harmful side effects.
The system works by first injecting a gel at the treatment site. The gel contains chemicals that combine with and activate an injected, attenuated form of a drug, such as a chemotherapeutic, to trigger its cancer-fighting effect only at the tumor or other targeted tissue. The experimental treatment has been successfully tested against tumors in mice, which experienced tumor shrinkage while maintaining healthier weights than mice receiving traditional chemotherapeutic treatments. Shasqi is funded by America’s Seed Fund powered by NSF. Photo credit: Shasqi
Jose M. Mejia Oneto, founder and CEO of Shasqi.
Detecting biological contaminants in water & pharmaceuticals
Spheryx, Inc. created a technology to monitor, count and characterize microscopic particles in a variety of fluids, such as water, chemicals, or even pharmaceuticals.
To learn more visit: https://spheryx.solutions/.
3D Printing Like Nature
Branch Technology combines 3D printing, industrial robotics, and conventional building materials to enable a new way to build.
To learn more visit: https://www.branch.technology/.